| Paul Mirone, | |
|
1600 Peninsula Dr Ste 9, Suite 9, Erie, PA 16505-4261 | |
| (814) 877-7035 | |
| Not Available |
| Full Name | Paul Mirone |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 1600 Peninsula Dr Ste 9, Erie, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043219850 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD063285L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Hamot Hospital | Erie, PA | Hospital |
| Saint Vincent Hospital | Erie, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regional Health Services Inc | 4880593722 | 484 |
News Archive
Sphere Medical, an innovator company in critical care monitoring and diagnostics equipment, has opened its new commercial production facility in St. Asaph, Wales.
Even though men use tanning beds at lower rates than women, men who tan tend to do it in riskier ways, according to a study by researchers at the University of Connecticut. The findings should help public health officials rethink how, and to whom, they're targeting anti-tanning messages.
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc., and Isis Pharmaceuticals, Inc., unveiled plans for an educational webinar about microRNA biology that will highlight several recent exciting discoveries in the field and showcase the therapeutic strategies based on microRNA.
Signal Genetics, the parent company of Myeloma Health LLC, and Pronto Diagnostics Ltd, both of which are privately held predictive genetic testing companies focused on oncology, announced that they have entered into a Distribution Agreement whereby Pronto will be the exclusive representative and distributor for Signal's Myeloma Prognostic Risk Signature (MyPRS) test in Israel.
› Verified 1 days ago
| Entity Name | Regional Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174520654 PECOS PAC ID: 4880593722 Enrollment ID: O20040108000694 |
News Archive
Sphere Medical, an innovator company in critical care monitoring and diagnostics equipment, has opened its new commercial production facility in St. Asaph, Wales.
Even though men use tanning beds at lower rates than women, men who tan tend to do it in riskier ways, according to a study by researchers at the University of Connecticut. The findings should help public health officials rethink how, and to whom, they're targeting anti-tanning messages.
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc., and Isis Pharmaceuticals, Inc., unveiled plans for an educational webinar about microRNA biology that will highlight several recent exciting discoveries in the field and showcase the therapeutic strategies based on microRNA.
Signal Genetics, the parent company of Myeloma Health LLC, and Pronto Diagnostics Ltd, both of which are privately held predictive genetic testing companies focused on oncology, announced that they have entered into a Distribution Agreement whereby Pronto will be the exclusive representative and distributor for Signal's Myeloma Prognostic Risk Signature (MyPRS) test in Israel.
› Verified 1 days ago
| Entity Name | Erie Physicians Network-upmc Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366726259 PECOS PAC ID: 1052587268 Enrollment ID: O20120110000034 |
News Archive
Sphere Medical, an innovator company in critical care monitoring and diagnostics equipment, has opened its new commercial production facility in St. Asaph, Wales.
Even though men use tanning beds at lower rates than women, men who tan tend to do it in riskier ways, according to a study by researchers at the University of Connecticut. The findings should help public health officials rethink how, and to whom, they're targeting anti-tanning messages.
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc., and Isis Pharmaceuticals, Inc., unveiled plans for an educational webinar about microRNA biology that will highlight several recent exciting discoveries in the field and showcase the therapeutic strategies based on microRNA.
Signal Genetics, the parent company of Myeloma Health LLC, and Pronto Diagnostics Ltd, both of which are privately held predictive genetic testing companies focused on oncology, announced that they have entered into a Distribution Agreement whereby Pronto will be the exclusive representative and distributor for Signal's Myeloma Prognostic Risk Signature (MyPRS) test in Israel.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul Mirone, 1600 Peninsula Dr Ste 9, Suite 9, Erie, PA 16505-4261 Ph: () - | Paul Mirone, 1600 Peninsula Dr Ste 9, Suite 9, Erie, PA 16505-4261 Ph: (814) 877-7035 |
News Archive
Sphere Medical, an innovator company in critical care monitoring and diagnostics equipment, has opened its new commercial production facility in St. Asaph, Wales.
Even though men use tanning beds at lower rates than women, men who tan tend to do it in riskier ways, according to a study by researchers at the University of Connecticut. The findings should help public health officials rethink how, and to whom, they're targeting anti-tanning messages.
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc., and Isis Pharmaceuticals, Inc., unveiled plans for an educational webinar about microRNA biology that will highlight several recent exciting discoveries in the field and showcase the therapeutic strategies based on microRNA.
Signal Genetics, the parent company of Myeloma Health LLC, and Pronto Diagnostics Ltd, both of which are privately held predictive genetic testing companies focused on oncology, announced that they have entered into a Distribution Agreement whereby Pronto will be the exclusive representative and distributor for Signal's Myeloma Prognostic Risk Signature (MyPRS) test in Israel.
› Verified 1 days ago
Mrs. Marsha Sigrid Dietrich-mclean, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 State St, Erie, PA 16550 Phone: 814-877-4922 Fax: 814-877-3622 | |
Matthew Heitzenrater, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 State St Ste 401, Erie, PA 16507 Phone: 814-877-5333 Fax: 814-877-5329 | |
Dr. Mary Katherine Lasher, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2501 W 12th St Ste C4, Erie, PA 16505 Phone: 814-461-6626 | |
Matthew Alan Potts, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5515 Peach St, Erie, PA 16509 Phone: 814-864-4031 | |
David Kruszewski, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3125 French St, Erie, PA 16504 Phone: 814-456-2047 | |
Harry Louis Haus, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3823 W 12th St, Erie, PA 16505 Phone: 814-490-3728 | |
Cecilia T. Urquico, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2501 W 12th St, Suite 1, Erie, PA 16505 Phone: 814-806-1144 Fax: 814-833-0659 |